Skip to search.
 TSX Down 2.72% TSX Ventures Down 2.06%

XOMA Corporation (XOMA)

-NasdaqGM
0.78 Down 0.05(6.10%) 4:00PM EDT
|After Hours : 0.78 0.00 (0.00%) 5:10PM EDT
Add to Portfolio
Prev Close:0.83
Open:0.83
Bid:0.77 x 20000
Ask:0.85 x 1000
1y Target Est:4.17
Beta:3.06558
Earnings Date:Nov 4 - Nov 9 (Est.)
Day's Range:0.78 - 0.84
52wk Range:0.69 - 5.95
Volume:1,499,392
Avg Vol (3m):5,845,130
Market Cap:92.52M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
XOMADown 6.10%92.52M
REGNDown 3.33%52.45B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.64
Quarterly EPS Est (Sep-15) :-0.16
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback